A Potassium phosphate, dibasic [USAN:JAN] CEP of the European Pharmacopoeia monograph is often referred to as a Potassium phosphate, dibasic [USAN:JAN] Certificate of Suitability (COS). The purpose of a Potassium phosphate, dibasic [USAN:JAN] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Potassium phosphate, dibasic [USAN:JAN] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Potassium phosphate, dibasic [USAN:JAN] to their clients by showing that a Potassium phosphate, dibasic [USAN:JAN] CEP has been issued for it. The manufacturer submits a Potassium phosphate, dibasic [USAN:JAN] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Potassium phosphate, dibasic [USAN:JAN] CEP holder for the record. Additionally, the data presented in the Potassium phosphate, dibasic [USAN:JAN] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Potassium phosphate, dibasic [USAN:JAN] DMF.
A Potassium phosphate, dibasic [USAN:JAN] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Potassium phosphate, dibasic [USAN:JAN] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Potassium phosphate, dibasic [USAN:JAN] suppliers with CEP (COS) on PharmaCompass.